Regulatory Affairs Syndicator

The Food and Drug Administration (FDA) announced today the approval of Ranexa (ranolazine), a new drug for the treatment of chronic angina. Ranexa, a new molecular entity (NME), is the first drug approved to treat chronic angina in over ten years.

The Food and Drug Administration (FDA) announced today the approval of Ranexa (ranolazine), a new drug for the treatment of chronic angina. Ranexa, a new molecular entity (NME), is the first drug approved to treat chronic angina in over ten years.

The Food and Drug Administration (FDA) announced today the approval of Ranexa (ranolazine), a new drug for the treatment of chronic angina. Ranexa, a new molecular entity (NME), is the first drug approved to treat chronic angina in over ten years.

Star-Banner - Federal regulators determined that a pet food company improperly tested or failed to test corn shipments for a deadly fungus that has been blamed for deaths and illness in dozens of dogs, a newspaper reported Monday. According to a government report …

Sucampo Pharmaceuticals and its partner will begin selling their new treatment for chronic constipation in adults this spring after the Food and Drug Administration on Tuesday approved the drug for market use.

What do barley and the late Rodney Dangerfield have in common? It could be said that neither one gets any respect - but that could be changing for barley now that the Food and Drug Administration has started extolling the health benefits of barley.

WASHINGTON - A drug to treat adult chronic constipation with no known cause won federal approval Tuesday.

WASHINGTON, Jan 31 (Reuters) - The U.S. Food and Drug Administration has approved a new prescription drug called Amitiza to treat adults with chronic constipation, one of the most common disorders among Americans, the agency said on Tuesday.

A drug to treat adult chronic constipation with no known cause won federal approval Tuesday. Lubiprostone works by increasing the secretion of intestinal fluids, which help ease the passage of stool and alleviate symptoms associated with chronic idiopathic constipation, the Food and Drug Administration said.

MADRID, Jan. 31 (UPI) — PharmaMar said Tuesday the Food and Drug Administration OK’d its investigational new drug application for Zalypsis. The company said it plans to launch U.S. trials of the anti-cancer agent in the second quarter of this year for treatment of solid tumors and lymphoma.

UPDATE 2-US FDA approves new drug to treat constipationReuters - 1 hour agoWASHINGTON, Jan 31 (Reuters) - The US Food and Drug Administration has approved a new prescription drug called Amitiza to treat adults with chronic constipation … FDA OK…

WASHINGTON, Jan 31 (Reuters) - The U.S. Food and Drug Administration has approved a new prescription drug called Amitiza to treat adults with chronic constipation, one of the most common disorders among Americans, the agency said on Tuesday.

WASHINGTON - A drug to treat adult chronic constipation with no known cause won federal approval Tuesday.

PravdaDrug Maker Elan Posts Narrower Net LossesOlberlin, KS - 13 hours ago… Analysts say Elan‘s fortunes depend heavily on whether the US Food and Drug Administration Food and Drug Administration permits the company‘s key drug in … U…

FDA OKs drug for chronic constipationSeattle Post Intelligencer - 3 hours ago… fluids, which help ease the passage of stool and alleviate symptoms associated with chronic idiopathic constipation, the Food and Drug Administration said. … Healt…